文献速递生殖医学

不明原因不孕促排卵后内膜厚度与活产率的关联

Endometrial thickness after ovarian stimulation with gonadotropin, clomiphene, or letrozole for unexplained infertility, and association with treatment outcomes.
PubMed 文献 · Fertil Steril · 2020-09-21

基于AMIGOS随机对照试验的前瞻性队列分析,纳入868对不明原因不孕夫妇共2459个促排卵联合宫腔内人工授精周期。总体上活产周期的扳机日子宫内膜厚度均值显著高于无活产周期,但校正促排卵药物类型后内膜厚度与活产率无显著关联,且各厚度组包括≤5 mm均有可观活产率。

要点

  • 校正促排卵药物类型后,内膜厚度与活产率无显著关联。
  • 内膜≤5 mm组仍有活产,不建议仅因内膜薄取消促排卵宫腔内人工授精周期。
  • 未校正时活产率随内膜厚度下降而降低,但该趋势在校正后不再成立。

核心结论

  • 在不明原因不孕的促排卵联合宫腔内人工授精治疗中,内膜厚度较高者活产率较高,但校正促排卵治疗类型后内膜厚度与活产率无显著关联。
  • 各内膜厚度组包括≤5 mm均可见可观活产率,提示不应因内膜薄而取消促排卵宫腔内人工授精周期。

研究设计与样本

  • 研究为生殖医学网络AMIGOS随机对照试验的前瞻性队列分析,多中心开展。
  • 纳入868对不明原因不孕夫妇,共2459个促排卵联合宫腔内人工授精治疗周期。
  • 采用广义估计方程计算各内膜厚度组活产的未校正与校正风险比。

主要发现

  • 有活产周期的扳机日(hCG日)平均内膜厚度显著大于无活产周期。
  • 以9–12 mm为参照组,内膜≤5 mm与6–8 mm组活产的未校正RR分别为0.48和0.92。
  • 趋势检验提示内膜越薄活产率越低,但校正促排卵药物后线性趋势不再成立。
  • 分层分析显示各治疗组间关联无差异。

关键数值与推荐

  • 参照内膜厚度组为9–12 mm。
  • 内膜≤5 mm组活产未校正RR为0.48,6–8 mm组为0.92。
  • 临床试验注册号NCT01044862。

临床怎么用

  • 促排卵联合宫腔内人工授精周期中,不应仅因内膜薄(包括≤5 mm)而取消周期。
  • 解读内膜厚度与活产关系时需考虑促排卵药物类型的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the association of endometrial thickness (EMT) with live birth rates (LBR) in ovarian stimulation with intrauterine insemination (OS-IUI) treatments for unexplained infertility. DESIGN: Prospective cohort analysis of the Reproductive Medicine Network's Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation (AMIGOS) randomized controlled trial. SETTING: Multicenter randomized controlled trial. PATIENTS: A total of 868 couples with unexplained infertility (n=2,459 cycles). INTERVENTIONS: OS-IUI treatment cycles (n = 2,459) as part of the AMIGOS clinical trial. MAIN OUTCOME MEASURES: Live birth rates; unadjusted and adjusted risk ratios (RR) for live birth by EMT category, calculated using generalized estimating equations. RESULTS: The overall mean EMT on day of human chorionic gonadotropin administration in cycles with a live birth was significantly greater than in those without. Compared to the referent EMT group of 9 to 12 mm, the unadjusted RR for live birth for the EMT groups of ≤5 and 6-8 were 0.48 and 0.92, respectively. The test for trend indicated evidence of decreasing LBR with decreasing EMT. After adjustment for ovarian stimulation medication, a linear trend was no longer supported. Stratified analyses revealed no differences in associations by treatment group. CONCLUSIONS: In OS-IUI for unexplained infertility, higher LBR are observed with increasing EMT; however, EMT is not significantly associated with LBR when adjusted for OS treatment type. Appreciable LBR are seen at all EMT, even those of ≤5 mm, suggesting that OS-IUI cycles should not be canceled for thin endometrium. CLINICAL TRIAL REGISTRATION NUMBER: NCT01044862.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Quaas AM, Gavrizi SZ, Peck JD, et al. Endometrial thickness after ovarian stimulation with gonadotropin, clomiphene, or letrozole for unexplained infertility, and association with treatment outcomes. Fertil Steril. 2020. PMID: 32972733. doi:10.1016/j.fertnstert.2020.07.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。